This paper discusses the recent Step 2 document of the International Conference on Harmonization on ethnic factors in the acceptability of foreign clinical data and its possible impact on industry.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Larson E. Exclusion of certain groups from clinical research. Image - J Nursing Scholar. 1994;26(3):185–190.
Draft Consensus Guideline Ethnic Factors in the Acceptability of Foreign Clinical Data, Released for Consultation at Step 2 of the ICH Process on March 6, 1997 by the ICH Steering Committee.
Mathews HW. Racial, ethnic and gender differences in response to medicines. Drug Metabol Drug Interact. 1995;12(2):77–91.
Yasuhara H. Ethnic factors in evaluation of drug efficacy and safety. Folia Pharmacol JPN. 1994;104(2):67–78.
Scrip Daily News. S00420768 of October 20, 1994.
Scrip. No. 2046, July 24, 1995, p. 27.
Edwards NC. Important considerations in the use of ethnicity as a study variable. Canad J Public Health. 1992;83(1):31–33.
Balant LP, Welling PG. Interethnic factors important for drug development and registration. Clin Res Regul Affairs. 1995;12(1):23–46.
Crews DE, Bindon JR. Ethnicity as a taxonomic tool in biomedical and biosocial research. Ethnicity Disease. 1991;1(1):42–49.
About this article
Cite this article
Dumitriu, H. Impact of the Ich Guideline on Ethnic Differences. Ther Innov Regul Sci 32, 141–144 (1998) doi:10.1177/009286159803200119
- Ethnic differences
- Foreign clinical data
- Bridging studies